Lannett Company Inc. recalls Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philad
Recalled June 10, 2026 · FDA recall D-0584-2026 · Lannett
Hazard
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint. · FDA Class II
Units
3984 bottles
Sold at
Nationwide within the United States
Description
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Product
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
Manufacturer(s)
Lannett Company Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →